Work

A Next-Generation Nanoparticles (NP)-Based Anti-Opioid Vaccine: Pre-Clinical Efficacy With a Focus on Innate Immunity Response

Year: 2025

Type: article

Source: Drug and Alcohol Dependence

DOI: 10.1016/j.drugalcdep.2024.112267

Authors: Fatima Hamid, Sara Rostamizadeh, Debra Walter, Chenming Zhang, Marco Pravetoni

Institutions: University of Minnesota, University of Washington, Virginia Tech

Language: English

Topic: Opioid Use Disorder Treatment

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute on Drug Abuse

Award: Novel nanovaccines against opioid use disorders

OpenAlex ID: W4407076273

FWCI:

Cites:

Cited by:

Related to: 10